AbstractMultiplemyeloma(MM)isaplasmacellneoplasmwithsignificantmolecularheterogeneity.Geneexpressionprofiling(GEP)hascontributedsignificantlytoourunderstandingoftheunderlyingbiologyandhasledtoseveralprognosticgenesignatures.However,thebestwaytoapplytheseGEPsignaturesinclinicalpracticeisunclear.Inthisstudy,weinvestigatedtheintegrationofprovenprognosticsignaturesforimprovedpatientriskstratification.ThreepubliclyavailableMMGEPdatasetsthaten
北京有哪些好的白癜风医院白癜风怎麽治
本文编辑:佚名
转载请注明出地址
http://www.iqoas.com/jbbj/1773.html